Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative

Cancer Cell

Volumn 12, Issue 3, 2007, Pages 192-199

  Peggs, Karl S ^a,b   Segal, Neil H ^a,b   Allison, James P ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CANCER VACCINE; CD20 ANTIGEN; CETUXIMAB; CYTOTOXIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DENILEUKIN DIFTITOX; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMATINIB; MONOCLONAL ANTIBODY; PANITUMUMAB; PERTUZUMAB; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN TYROSINE KINASE; RITUXIMAB; TRASTUZUMAB; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; BONE MARROW CANCER; BONE MARROW SUPPRESSION; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER THERAPY; CELL DEATH; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG DOSE ESCALATION; DRUG MECHANISM; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; IMMUNE RESPONSE; KIDNEY CARCINOMA; MONOTHERAPY; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TARGET CELL; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

EID: 34548227265     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2007.08.023     Document Type: Note

References (64)

1. Appel S., Balabanov S., Brummendorf T.H., and Brossart P. Stem Cells 23 (2005) 1082-1088
2. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., and Ahmed R. Nature 439 (2006) 682-687
3. Barnett B., Kryczek I., Cheng P., Zou W., and Curiel T.J. Am. J. Reprod. Immunol. 54 (2005) 369-377
4. Bergmann-Leitner E.S., and Abrams S.I. Cancer Immunol. Immunother. 50 (2001) 445-455
5. Berkers C.R., and Ovaa H. Trends Pharmacol. Sci. 26 (2005) 252-257
6. Biagi E., Rousseau R., Yvon E., Schwartz M., Dotti G., Foster A., Havlik-Cooper D., Grilley B., Gee A., Baker K., et al. Clin. Cancer Res. 11 (2005) 6916-6923
7. Burchert A., Wolfl S., Schmidt M., Brendel C., Denecke B., Cai D., Odyvanova L., Lahaye T., Muller M.C., Berg T., et al. Blood 101 (2003) 259-264
8. Burgess M.R., Skaggs B.J., Shah N.P., Lee F.Y., and Sawyers C.L. Proc. Natl. Acad. Sci. USA 102 (2005) 3395-3400
9. Cartron G., Dacheux L., Salles G., Solal-Celigny P., Bardos P., Colombat P., and Watier H. Blood 99 (2002) 754-758
10. Changelian P.S., Flanagan M.E., Ball D.J., Kent C.R., Magnuson K.S., Martin W.H., Rizzuti B.J., Sawyer P.S., Perry B.D., Brissette W.H., et al. Science 302 (2003) 875-878
11. Chu P.G., Chen Y.Y., Molina A., Arber D.A., and Weiss L.M. Leuk. Lymphoma 43 (2002) 2335-2341
12. Dannull J., Su Z., Rizzieri D., Yang B.K., Coleman D., Yancey D., Zhang A., Dahm P., Chao N., Gilboa E., and Vieweg J. J. Clin. Invest. 115 (2005) 3623-3633
13. Dietz A.B., Souan L., Knutson G.J., Bulur P.A., Litzow M.R., and Vuk-Pavlovic S. Blood 104 (2004) 1094-1099
14. Dudley M.E., Wunderlich J.R., Robbins P.F., Yang J.C., Hwu P., Schwartzentruber D.J., Topalian S.L., Sherry R., Restifo N.P., Hubicki A.M., et al. Science 298 (2002) 850-854
15. Feng H., Zeng Y., Graner M.W., Likhacheva A., and Katsanis E. Blood 101 (2003) 245-252
16. Feugier P., Van Hoof A., Sebban C., Solal-Celigny P., Bouabdallah R., Ferme C., Christian B., Lepage E., Tilly H., Morschhauser F., et al. J. Clin. Oncol. 23 (2005) 4117-4126
17. Fong, L., Kavanagh, B., Rini, B.I., Shaw, V., Weinberg, V., and Small, E.J. (2006). J. Clin. Oncol. 2006 ASCO Annual Meeting Proceedings 24, 2508.
18. French R.R., Chan H.T., Tutt A.L., and Glennie M.J. Nat. Med. 5 (1999) 548-553
19. Ghiringhelli F., Larmonier N., Schmitt E., Parcellier A., Cathelin D., Garrido C., Chauffert B., Solary E., Bonnotte B., and Martin F. Eur. J. Immunol. 34 (2004) 336-344
20. Iwai Y., Terawaki S., and Honjo T. Int. Immunol. 17 (2005) 133-144
21. Jing N., and Tweardy D.J. Anticancer Drugs 16 (2005) 601-607
22. Klebanoff C.A., Khong H.T., Antony P.A., Palmer D.C., and Restifo N.P. Trends Immunol. 26 (2005) 111-117
23. Ko K., Yamazaki S., Nakamura K., Nishioka T., Hirota K., Yamaguchi T., Shimizu J., Nomura T., Chiba T., and Sakaguchi S. J. Exp. Med. 202 (2005) 885-891
24. Korman A.J., Peggs K.S., and Allison J.P. Adv. Immunol. 90C (2006) 297-339
25. Krause D.S., and Van Etten R.A. N. Engl. J. Med. 353 (2005) 172-187
26. Krieg A.M. J. Clin. Invest. 117 (2007) 1184-1194
27. Lasota J., and Miettinen M. Semin. Diagn. Pathol. 23 (2006) 91-102
28. Melero I., Shuford W.W., Newby S.A., Aruffo A., Ledbetter J.A., Hellstrom K.E., Mittler R.S., and Chen L. Nat. Med. 3 (1997) 682-685
29. Melero I., Hervas-Stubbs S., Glennie M., Pardoll D.M., and Chen L. Nat. Rev. Cancer 7 (2007) 95-106
30. Michor F., Hughes T.P., Iwasa Y., Branford S., Shah N.P., Sawyers C.L., and Nowak M.A. Nature 435 (2005) 1267-1270
31. Molldrem J.J., Lee P.P., Kant S., Wieder E., Jiang W., Lu S., Wang C., and Davis M.M. J. Clin. Invest. 111 (2003) 639-647
32. Muller A.J., and Scherle P.A. Nat. Rev. Cancer 6 (2006) 613-625
33. Nishikawa H., Jager E., Ritter G., Old L.J., and Gnjatic S. Blood 106 (2005) 1008-1011
34. Nowak A.K., Robinson B.W., and Lake R.A. Cancer Res. 62 (2002) 2353-2358
35. Nowak A.K., Lake R.A., Marzo A.L., Scott B., Heath W.R., Collins E.J., Frelinger J.A., and Robinson B.W. J. Immunol. 170 (2003) 4905-4913
36. Nowak A.K., Robinson B.W., and Lake R.A. Cancer Res. 63 (2003) 4490-4496
37. Obeid M., Tesniere A., Ghiringhelli F., Fimia G.M., Apetoh L., Perfettini J.L., Castedo M., Mignot G., Panaretakis T., Casares N., et al. Nat. Med. 13 (2007) 54-61
38. O'Dwyer M.E., Mauro M.J., Kurilik G., Mori M., Balleisen S., Olson S., Magenis E., Capdeville R., and Druker B.J. Blood 100 (2002) 1628-1633
39. Parmiani G., De Filippo A., Novellino L., and Castelli C. J. Immunol. 178 (2007) 1975-1979
40. Peggs K., and Mackinnon S. N. Engl. J. Med. 348 (2003) 1048-1050
41. Peggs K.S., Quezada S.A., Korman A.J., and Allison J.P. Curr. Opin. Immunol. 18 (2006) 206-213
42. Press R.D., Love Z., Tronnes A.A., Yang R., Tran T., Mongoue-Tchokote S., Mori M., Mauro M.J., Deininger M.W., and Druker B.J. Blood 107 (2006) 4250-4256
43. Rapoport A.P., Stadtmauer E.A., Aqui N., Badros A., Cotte J., Chrisley L., Veloso E., Zheng Z., Westphal S., Mair R., et al. Nat. Med. 11 (2005) 1230-1237
44. Riley J.L., Mao M., Kobayashi S., Biery M., Burchard J., Cavet G., Gregson B.P., June C.H., and Linsley P.S. Proc. Natl. Acad. Sci. USA 99 (2002) 11790-11795
45. Roche-Lestienne C., Lai J.L., Darre S., Facon T., and Preudhomme C. N. Engl. J. Med. 348 (2003) 2265-2266
46. Rousselot P., Huguet F., Rea D., Legros L., Cayuela J.M., Maarek O., Blanchet O., Marit G., Gluckman E., Reiffers J., et al. Blood 109 (2007) 58-60
47. Rovere P., Sabbadini M.G., Vallinoto C., Fascio U., Zimmermann V.S., Bondanza A., Ricciardi-Castagnoli P., and Manfredi A.A. J. Leukoc. Biol. 66 (1999) 345-349
48. Rubin B.P., and Duensing A. Lab. Invest. 86 (2006) 981-986
49. Seggewiss R., Lore K., Greiner E., Magnusson M.K., Price D.A., Douek D.C., Dunbar C.E., and Wiestner A. Blood 105 (2005) 2473-2479
50. Sheridan C. Nat. Biotechnol. 24 (2006) 475-476
51. Shi Y., Evans J.E., and Rock K.L. Nature 425 (2003) 516-521
52. Sjoblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., et al. Science 314 (2006) 268-274
53. Sorel N., Roy L., Martineau G., Guilhot F., Turhan A.G., and Chomel J.C. Blood 108 (2006) 1782-1783
54. Sotomayor E.M., Borrello I., Rattis F.M., Cuenca A.G., Abrams J., Staveley-O'Carroll K., and Levitsky H.I. Blood 98 (2001) 1070-1077
55. Sugamura K., Ishii N., and Weinberg A.D. Nat. Rev. Immunol. 4 (2004) 420-431
56. Suntharalingam G., Perry M.R., Ward S., Brett S.J., Castello-Cortes A., Brunner M.D., and Panoskaltsis N. N. Engl. J. Med. 355 (2006) 1018-1028
57. Takeda K., Stagg J., Yagita H., Okumura K., and Smyth M.J. Oncogene 26 (2007) 3745-3757
58. Tamada K., and Chen L. Cancer Immunol. Immunother. 55 (2006) 355-362
59. Tefferi A., and Pardanani A. Int. J. Hematol. 79 (2004) 441-447
60. Tivol E.A., Borriello F., Schweitzer A.N., Lynch W.P., Bluestone J.A., and Sharpe A.H. Immunity 3 (1995) 541-547
61. Tong A.W., and Stone M.J. Cancer Gene Ther. 10 (2003) 1-13
62. Uno T., Takeda K., Kojima Y., Yoshizawa H., Akiba H., Mittler R.S., Gejyo F., Okumura K., Yagita H., and Smyth M.J. Nat. Med. 12 (2006) 693-698
63. Viola A., and Lanzavecchia A. Science 273 (1996) 104-106
64. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P., Thompson C.B., Griesser H., and Mak T.W. Science 270 (1995) 985-988